Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed cases of bronchial asthma. Patient between 18 and 60 years of age. Patient of either sex. Mild to moderate persistent asthma cases. Patient willing to participate in the study.
Exclusion criteria
Exclusion criteria: Patients below the age of 18 and above 60 years of age . Patients having Chronic obstructive pulmonary disease (COPD),Pulmonary tuberculosis, Pneumonia, Occupational lung disease ,Lung carcinoma and other respiratory diseases. Patients having diabetes mellitus, hypertension, cardiovascular disease, impaired renal function, impaired liver function and other malignancies. Severe Exacerbation (FEV1 or PEF less than 50 percent predicted) or asthma related intubation. Pregnant or lactating women. Patients who had received corticosteroids, bronchodilators or CAM therapy within 2 weeks prior to enrollment. Patients on other therapies (allopathic, homeopathic or other drugs) along with our trial drug. Patients who refuse to give written consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement in the subjective parameters such as cough, sputum, dyspnea, wheezing and crepitations in response to the treatment. 2.Improvement in FEV1,PEF,FEV1/FVC ratio in response to the treatment.Timepoint: 1.Assessment of the subjective parameters at baseline, 15th, 30th and 45th day. 2.Assessment of the objective parameters at baseline and 45th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Improvement in ACT score in response to the treatment. 2.Improvement in the Quality of life in response to the treatment.Timepoint: 1.Assessment of ACT score at baseline,15th 30th and 45th day. 2.Assessment of the Quality of life at baseline and 45th day. | — |
Countries
India
Contacts
Ayurvedic and Unani Tibbia College and Hospital, Karol Bagh, New Delhi